The increased expression of SMC1 gene in triple negative breast cancer supports the idea that SMC1 biosynthesis is tightly regulated in normal cells and that an imbalance in the amount of this protein may directly affect the cell survival and other cellular functions [23]–[26]. The gene discussed is SMC1A; the disease is triple-negative breast carcinoma.